QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
QQQ   377.93 (+1.02%)
AAPL   148.64 (-0.03%)
MSFT   308.13 (-0.33%)
FB   328.69 (+1.26%)
GOOGL   2,748.94 (-0.09%)
TSLA   1,024.86 (+12.66%)
AMZN   3,320.37 (-0.46%)
NVDA   231.66 (+1.94%)
BABA   176.17 (-0.86%)
NIO   41.27 (+6.15%)
CGC   13.57 (+1.42%)
GE   105.43 (+1.33%)
AMD   122.36 (+2.12%)
MU   68.76 (+1.85%)
T   25.64 (+0.59%)
F   16.00 (-1.72%)
ACB   7.18 (+1.56%)
DIS   172.01 (+1.53%)
PFE   43.15 (-0.02%)
BA   212.87 (-0.05%)
AMC   36.83 (+0.63%)
NASDAQ:ERAS

Erasca Stock Forecast, Price & News

$19.27
+0.38 (+2.01 %)
(As of 10/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$18.52
$19.73
50-Day Range
$16.98
$24.34
52-Week Range
$14.51
$24.47
Volume187,641 shs
Average Volume420,141 shs
Market Capitalization$2.34 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ERAS News and Ratings via Email

Sign-up to receive the latest news and ratings for Erasca and its competitors with MarketBeat's FREE daily newsletter.


Erasca logo

About Erasca

Erasca Inc. is a clinical-stage precision oncology company singularly focused on discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Erasca Inc. is based in SAN DIEGO.

Headlines

Erasca (NASDAQ:ERAS) Shares Up 6%
October 20, 2021 |  americanbankingnews.com
Short Interest in Erasca Inc (NASDAQ:ERAS) Increases By 31.2%
October 18, 2021 |  americanbankingnews.com
Erasca (NASDAQ:ERAS) Shares Gap Up to $18.02
October 14, 2021 |  americanbankingnews.com
Erasca (NASDAQ:ERAS) Shares Down 4.9%
October 12, 2021 |  americanbankingnews.com
Erasca (NASDAQ:ERAS) Stock Price Up 6.8%
October 11, 2021 |  americanbankingnews.com
Erasca (NASDAQ:ERAS) Shares Gap Down to $19.10
October 8, 2021 |  americanbankingnews.com
Erasca (NASDAQ:ERAS) Trading Down 6.9%
October 6, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ERAS
Employees
2,021
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$2.34 billion
Next Earnings Date
11/25/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.76 out of 5 stars

Medical Sector

842nd out of 1,360 stocks

Pharmaceutical Preparations Industry

417th out of 667 stocks

Analyst Opinion: 4.4Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Erasca (NASDAQ:ERAS) Frequently Asked Questions

Is Erasca a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Erasca in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Erasca stock.
View analyst ratings for Erasca
or view top-rated stocks.

What stocks does MarketBeat like better than Erasca?

Wall Street analysts have given Erasca a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Erasca wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Erasca?

Erasca saw a increase in short interest in September. As of September 30th, there was short interest totaling 3,110,000 shares, an increase of 31.2% from the September 15th total of 2,370,000 shares. Based on an average daily trading volume, of 495,700 shares, the short-interest ratio is currently 6.3 days. Currently, 4.5% of the shares of the stock are short sold.
View Erasca's Short Interest
.

When is Erasca's next earnings date?

Erasca is scheduled to release its next quarterly earnings announcement on Thursday, November 25th 2021.
View our earnings forecast for Erasca
.

How were Erasca's earnings last quarter?

Erasca Inc (NASDAQ:ERAS) released its earnings results on Thursday, August, 26th. The company reported ($1.20) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.71) by $0.49.
View Erasca's earnings history
.

What price target have analysts set for ERAS?

5 Wall Street analysts have issued 12 month price targets for Erasca's shares. Their forecasts range from $25.00 to $28.00. On average, they anticipate Erasca's share price to reach $26.50 in the next twelve months. This suggests a possible upside of 37.5% from the stock's current price.
View analysts' price targets for Erasca
or view top-rated stocks among Wall Street analysts.

When did Erasca IPO?

(ERAS) raised $262 million in an initial public offering (IPO) on Thursday, July 15th 2021. The company issued 17,500,000 shares at $14.00-$16.00 per share.

What is Erasca's stock symbol?

Erasca trades on the NASDAQ under the ticker symbol "ERAS."

Who are Erasca's major shareholders?

Erasca's stock is owned by a number of retail and institutional investors. Top institutional investors include Strs Ohio (0.00%).

Which institutional investors are buying Erasca stock?

ERAS stock was acquired by a variety of institutional investors in the last quarter, including Strs Ohio.

How do I buy shares of Erasca?

Shares of ERAS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Erasca's stock price today?

One share of ERAS stock can currently be purchased for approximately $19.27.

How much money does Erasca make?

Erasca has a market capitalization of $2.34 billion.

How many employees does Erasca have?

Erasca employs 2,021 workers across the globe.

What is Erasca's official website?

The official website for Erasca is www.erasca.com.

How can I contact Erasca?

The company can be reached via phone at 858-465-6511 or via email at [email protected].


This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.